State Of Wisconsin Investment Board Relmada Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$18.3 - $37.02 $10,577 - $21,397	-578 Reduced 2.36%	23,898 $885,000
Q2 2022 Aug 15, 2022	BUY	$16.5 - $30.34 $59,004 - $108,495	3,576 Added 17.11%	24,476 $465,000
Q1 2022 May 13, 2022	BUY	$16.72 - $26.99 $349,448 - $564,091	20,900 New	20,900 $564,000
Q4 2021 Feb 11, 2022	SELL	$16.93 - $26.82 $340,293 - $539,082	-20,100 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$29.88 - $39.8 $74,700 - $99,500	-2,500 Reduced 11.06%	20,100 $645,000
Q2 2020 Aug 12, 2020	BUY	$31.59 - $49.98 $713,934 - $1.13 Million	22,600 New	22,600 $1.01 Million

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.